Kancera: Letter of intent with Recardio Inc. - Redeye

Redeye comments on Kancera’s announcement of a letter of intent with Recardio Inc. regarding the out-licensing of KAND567 and KAND145. The structure and payment terms of the transaction have not yet been finalised, and we await further information before making any changes.

Länk till analysen i sin helhet: https://www.redeye.se/research/1087352/kancera-letter-of-intent-with-recardio-inc?utm_source=finwire&utm_medium=RSS